91 related articles for article (PubMed ID: 9713966)
21. LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma.
Campbell RA; Manyak SJ; Yang HH; Sjak-Shie NN; Chen H; Gui D; Popoviciu L; Wang C; Gordon M; Pang S; Bonavida B; Said J; Berenson JR
Int J Oncol; 2006 Jun; 28(6):1409-17. PubMed ID: 16685443
[TBL] [Abstract][Full Text] [Related]
22. Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid.
Huang H; Wu D; Fu J; Chen G
Leuk Lymphoma; 2009 Jun; 50(6):966-73. PubMed ID: 19373597
[TBL] [Abstract][Full Text] [Related]
23. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation.
Yang QJ; Zhou LY; Mu YQ; Zhou QX; Luo JY; Cheng L; Deng ZL; He TC; Haydon RC; He BC
Int J Oncol; 2012 Jul; 41(1):153-60. PubMed ID: 22485251
[TBL] [Abstract][Full Text] [Related]
24. All-trans-retinoic acid inhibits growth of human pancreatic cancer cell lines.
Bold RJ; Ishizuka J; Townsend CM; Thompson JC
Pancreas; 1996 Mar; 12(2):189-95. PubMed ID: 8720668
[TBL] [Abstract][Full Text] [Related]
25. Effects of all-trans retinoic acid and interferon alpha in peripheral neuroectodermal tumor cell cultures and xenografts.
Rosolen A; Favaretto G; Masarotto G; Cavazzana A; Zanesco L; Frascella E
Int J Oncol; 1998 Nov; 13(5):943-9. PubMed ID: 9772283
[TBL] [Abstract][Full Text] [Related]
26. IL-10 in myeloma cells.
Otsuki T; Yata K; Sakaguchi H; Uno M; Fujii T; Wada H; Sugihara T; Ueki A
Leuk Lymphoma; 2002 May; 43(5):969-74. PubMed ID: 12148907
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
[TBL] [Abstract][Full Text] [Related]
28. All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice.
Tabata C; Tabata R; Hirayama N; Yasumitsu A; Yamada S; Murakami A; Iida S; Tamura K; Terada T; Kuribayashi K; Fukuoka K; Nakano T
Eur Respir J; 2009 Nov; 34(5):1159-67. PubMed ID: 19443527
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans retinoic acid on the growth of cultured human pancreas cancer cells and pancreas tumor xenografts in immunodeficient mice.
Avila GE; Zheng X; Cui XX; Ryan AD; Hansson A; Suh J; Rabson AB; Chang RL; Shih WJ; Lin Y; Crowell P; Lu YP; Lou YR; Conney AH
J Pharmacol Exp Ther; 2005 Oct; 315(1):170-87. PubMed ID: 15976015
[TBL] [Abstract][Full Text] [Related]
31. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.
Coffey DC; Kutko MC; Glick RD; Butler LM; Heller G; Rifkind RA; Marks PA; Richon VM; La Quaglia MP
Cancer Res; 2001 May; 61(9):3591-4. PubMed ID: 11325825
[TBL] [Abstract][Full Text] [Related]
32. [Effects of retinoic acid on proliferation and differentiation of human lung squamous carcinoma cell line].
Su XL; Hu CP; Wu ES
Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):579-81. PubMed ID: 12516412
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
34. Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells.
Huang YW; Richardson JA; Vitetta ES
Cancer Res; 1995 Feb; 55(3):610-6. PubMed ID: 7834632
[TBL] [Abstract][Full Text] [Related]
35. The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell lines.
Coleman EJ; Brooks KJ; Smallshaw JE; Vitetta ES
J Immunother; 2006; 29(5):489-98. PubMed ID: 16971805
[TBL] [Abstract][Full Text] [Related]
36. Long-term engraftment of fresh human myeloma cells in SCID mice.
Feo-Zuppardi FJ; Taylor CW; Iwato K; Lopez MH; Grogan TM; Odeleye A; Hersh EM; Salmon SE
Blood; 1992 Dec; 80(11):2843-50. PubMed ID: 1450409
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms of arsenic trioxide-induced apoptosis in myeloma cells].
Zhou Y; Huang X; Cai X
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):181-3. PubMed ID: 11783079
[TBL] [Abstract][Full Text] [Related]
38. Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma.
Sanchez E; Gillespie A; Tang G; Ferros M; Harutyunyan NM; Vardanyan S; Gottlieb J; Li M; Wang CS; Chen H; Berenson JR
Clin Cancer Res; 2016 Jul; 22(13):3383-97. PubMed ID: 26960399
[TBL] [Abstract][Full Text] [Related]
39. Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.
Timm MM; Kimlinger TK; Haug JL; Kline MP; Greipp PR; Rajkumar SV; Kumar SK
Leukemia; 2006 Oct; 20(10):1863-9. PubMed ID: 16932343
[TBL] [Abstract][Full Text] [Related]
40. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.
Dingli D; Timm M; Russell SJ; Witzig TE; Rajkumar SV
Clin Cancer Res; 2002 Dec; 8(12):3948-54. PubMed ID: 12473611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]